Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

被引：28

作者：

Laurenti, Luca ^{[1
]}

Innocenti, Idanna ^{[1
]}

Autore, Francesco ^{[1
]}

Vannata, Barbara ^{[2
]}

Efremov, Dimitar G. ^{[3
]}

Ciolli, Stefania ^{[4
]}

Del Poeta, Giovanni ^{[5
]}

Mauro, Francesca Romana ^{[6
]}

Cortelezzi, Agostino ^{[7
]}

Borza, Paola Anticoli ^{[8
]}

Ghio, Francesco ^{[9
]}

Mondello, Patrizia ^{[10
]}

Murru, Roberta ^{[11
]}

Gozzetti, Alessandro ^{[12
]}

Cariccio, Maria Rosa Lanza ^{[13
]}

Piccirillo, Nicola ^{[1
]}

Boncompagni, Riccardo ^{[4
]}

Cantonetti, Maria ^{[5
]}

Del Principe, Maria Ilaria ^{[5
]}

Reda, Gianluigi ^{[7
]}

Bongarzoni, Velia ^{[8
]}

Cervetti, Giulia ^{[9
]}

Pitini, Vincenzo ^{[10
]}

Foa, Robin ^{[6
]}

Sica, Simona ^{[1
]}

D'Arena, Giovanni ^{[14
]}

机构：

[1] Univ Cattolica Sacro Cuore, A Gemelli Policlin, I-00168 Rome, Italy

[2] G Panico Hosp, Haematol Unit, Lecce, Italy

[3] Int Ctr Genet Engn & Biotechnol, Monterotondo, Italy

[4] Careggi Hosp, Florence, Italy

[5] Univ Roma Tor Vergata, Rome, Italy

[6] Univ Roma La Sapienza, Umberto Policlin I, Rome, Italy

[7] Univ Milan, IRCCS Ca Granda, I-20122 Milan, Italy

[8] San Giovanni Addolorata Hosp, Rome, Italy

[9] Santa Chiara Hosp, Pisa, Italy

[10] Univ Messina, Messina, Italy

[11] A Businco Hosp, Cagliari, Italy

[12] Le Scotte Policlin, Siena, Italy

[13] Paolo Giaccone Policlin, Palermo, Italy

[14] IRCCS Ctro Riferimento Oncol Basilicata, Rionero In Vulture, Italy

来源：

LEUKEMIA RESEARCH | 2015年 / 39卷 / 10期

关键词：

CLL; Bendamustine; Rituximab; Elderly patients; First-line treatment; 1ST-LINE TREATMENT; CYCLOPHOSPHAMIDE; CHLORAMBUCIL; FLUDARABINE; TRIAL;

D O I：

10.1016/j.leukres.2015.07.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The front-line therapy for CLL young and fit patients is chemo-immunotherapy with fludarabine-cyclophosphamide-rituximab (FCR). FCR regimen results in a significant myelosuppression and high rates of early and late infections especially in elderly patients. German CLL study group compared FCR vs. bendamustine-rituximab (BR) in fit untreated patients. The response rates with BR or FCR were comparable, BR could be an alternative 1st-line treatment for elderly patients. Here we report retrospective data of 70 elderly (>= 65 years) CLL patients from 12 Italian centers treated with BR as front-line therapy. The primary end points were overall response rate (complete remission/partial remission) and safety. Forty-seven males and 23 females, with a median age of 72 years, were included in the study. Eight patients were unfit for CIRS. The OR rate was 88.6% (31.4% CR and 57.2% PR). Progression free survival, treatment free survival and overall survival rates at 2-years were 79%, 90.3% and 89.6%, respectively. Only del17 was independent unfavorable parameter on the response rate and PFS. Our results indicate that BR front-line at standard dose provides a high response rate with a good safety profile, even if more than 50% of patients experienced a bendamustine dose reduction until 70 mg/m(2). (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：1066 / 1070

页数：5

共 21 条

[21] Non-Hodgkin's Lymphomas, Version 4.2014 [J].

Zelenetz, Andrew D. ;

Gordon, Leo I. ;

Wierda, William G. ;

Abramson, Jeremy S. ;

Advani, Ranjana H. ;

Andreadis, C. Babis ;

Bartlett, Nancy ;

Byrd, John C. ;

Czuczman, Myron S. ;

Fayad, Luis E. ;

Fisher, Richard I. ;

Glenn, Martha J. ;

Harris, Nancy Lee ;

Hoppe, Richard T. ;

Horwitz, Steven M. ;

Kelsey, Christopher R. ;

Kim, Youn H. ;

Krivacic, Susan ;

LaCasce, Ann S. ;

Nademanee, Auayporn ;

Porcu, Pierluigi ;

Press, Oliver ;

Rabinovitch, Rachel ;

Reddy, Nishitha ;

Reid, Erin ;

Saad, Ayman A. ;

Sokol, Lubomir ;

Swinnen, Lode J. ;

Tsien, Christina ;

Vose, Julie M. ;

Yahalom, Joachim ;

Zafar, Nadeem ;

Dwyer, Mary ;

Sundar, Hema .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (09) :1282-1303

← 1 2 3 →